Romania integrates MASLD into the national infrastructure for chronic liver disease screening through the LIVE(RO)3 project.
Utrogestan officially approved in Romania for the prevention of preterm birth in women with a short cervix
Adaugă Medic24 în sursele preferate Google
The medicine Utrogestan has received official approval from the Romanian National Agency for Medicines and Medical Devices (ANMDMR) for a new important therapeutic indication: the prevention of preterm birth in pregnant women with a short cervix (≤ 25 mm).
The new indication concerns vaginal administration of the product and is supported by international recommendations with level A evidence, according to the ISUOG Guidelines 2022 and SOGC Guidelines 2020. Moreover, this therapy was already acknowledged in Romania through the 2019 Obstetrics-Gynecology Guidelines and the Minister of Health’s Order issued in December 2020. The recent update of the Utrogestan leaflet now provides a firm legal basis for prescribing the drug in this clinical scenario.
Key aspects of Utrogestan use:
- It can be administered vaginally in a daily dose exceeding 200 mg in a single application;
- Administration is allowed up to and including the 34th week of pregnancy;
- It is recommended for patients diagnosed with a short cervix (≤ 25 mm), a condition often associated with an increased risk of preterm birth.
According to clinical data presented by the Romanian Society of Obstetrics and Gynecology (SROG), the efficacy and safety of Utrogestan are supported by a substantial body of evidence: more than 18,000 patients in randomized clinical trials and over 10,000 documented cases in assisted reproduction settings.
“We consider this approval a significant step for obstetric practice and recommend the application of this therapeutic indication in the direct interest of the patient,” stated Prof. Elvira Brătila, President of SROG.
Medic24 - Romania's healthcare system at a glance
On hospital duty shifts in public hospitals, professional burnout, patient safety and the fragility of the medical system.
A mosquito bite is usually benign, but some local reactions, allergies or mosquito-borne infections may require medical attention.
Alexandru Rafila says healthcare underfunding must be addressed through better budget revenue collection, digitalization, AI and structural reforms.
CMR calls for amendments to the draft Salary Law, including higher salary coefficients for doctors and maintaining the on-call bonus.
Resident doctors warn that the draft new salary law could reduce incomes due to the absence of minimum guaranteed bonuses.
